South Africa
· Delayed Price · Currency is ZAR Ascendis Health Statistics
Total Valuation
Ascendis Health has a market cap or net worth of ZAR 450.75 million. The enterprise value is 454.70 million.
| Market Cap | 450.75M |
| Enterprise Value | 454.70M |
Important Dates
The next estimated earnings date is Friday, September 27, 2024.
| Earnings Date | Sep 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Ascendis Health has 626.05 million shares outstanding. The number of shares has increased by 3.27% in one year.
| Shares Outstanding | 626.05M |
| Shares Change (YoY) | +3.27% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 11.69% |
| Owned by Institutions (%) | 0.04% |
| Float | 178.83M |
Valuation Ratios
The trailing PE ratio is 10.84.
| PE Ratio | 10.84 |
| Forward PE | n/a |
| PS Ratio | 0.31 |
| PB Ratio | 0.73 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.04, with an EV/FCF ratio of -10.81.
| EV / Earnings | 7.94 |
| EV / Sales | 0.31 |
| EV / EBITDA | 7.04 |
| EV / EBIT | 60.15 |
| EV / FCF | -10.81 |
Financial Position
The company has a current ratio of 1.88, with a Debt / Equity ratio of 7.98.
| Current Ratio | 1.88 |
| Quick Ratio | 0.91 |
| Debt / Equity | 7.98 |
| Debt / EBITDA | 0.76 |
| Debt / FCF | -1.17 |
| Interest Coverage | 0.61 |
Financial Efficiency
Return on equity (ROE) is 7.04% and return on invested capital (ROIC) is 0.74%.
| Return on Equity (ROE) | 7.04% |
| Return on Assets (ROA) | 0.46% |
| Return on Capital (ROIC) | 0.74% |
| Revenue Per Employee | 105.15M |
| Profits Per Employee | 4.09M |
| Employee Count | 14 |
| Asset Turnover | 1.45 |
| Inventory Turnover | 2.33 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.50% in the last 52 weeks. The beta is 0.64, so Ascendis Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | +12.50% |
| 50-Day Moving Average | 72.94 |
| 200-Day Moving Average | 77.29 |
| Relative Strength Index (RSI) | 48.06 |
| Average Volume (20 Days) | 915,775 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ascendis Health had revenue of ZAR 1.47 billion and earned 57.29 million in profits. Earnings per share was 0.09.
| Revenue | 1.47B |
| Gross Profit | 585.18M |
| Operating Income | 7.56M |
| Pretax Income | 40.37M |
| Net Income | 57.29M |
| EBITDA | 64.61M |
| EBIT | 7.56M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 45.38 million in cash and 49.32 million in debt, giving a net cash position of -3.95 million or -0.01 per share.
| Cash & Cash Equivalents | 45.38M |
| Total Debt | 49.32M |
| Net Cash | -3.95M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 618.27M |
| Book Value Per Share | 0.99 |
| Working Capital | 359.64M |
Cash Flow
In the last 12 months, operating cash flow was -4.98 million and capital expenditures -37.09 million, giving a free cash flow of -42.07 million.
| Operating Cash Flow | -4.98M |
| Capital Expenditures | -37.09M |
| Free Cash Flow | -42.07M |
| FCF Per Share | -0.07 |
Margins
Gross margin is 39.75%, with operating and profit margins of 0.51% and 3.89%.
| Gross Margin | 39.75% |
| Operating Margin | 0.51% |
| Pretax Margin | 2.74% |
| Profit Margin | 3.89% |
| EBITDA Margin | 4.39% |
| EBIT Margin | 0.51% |
| FCF Margin | -2.86% |
Dividends & Yields
Ascendis Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.27% |
| Shareholder Yield | -3.27% |
| Earnings Yield | 12.71% |
| FCF Yield | -9.33% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |